Cadherin expression in ovarian carcinoma and malignant mesothelioma cell effusions

被引:21
|
作者
Sivertsen, Stine
Berner, Aasmund
Michael, Claire W.
Bedrossian, Carlos
Davidson, Ben [1 ]
机构
[1] Univ Oslo, Dept Pathol, Norwegian Radium Hosp, Natl Hosp, N-0310 Oslo, Norway
[2] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[3] Norwegian Amer Hosp, Chicago, IL USA
关键词
cadherins; carcinoma; ovarian; primary peritoneal; mesothelioma;
D O I
10.1159/000326027
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objective To analyze potential differences in cadherin expression between ovarian carcinoma/primary peritoneal carcinoma (OC/PPC) and malignant mesothelioma (MM) at this anatomic site. Study Design MM (N = 24) and OC/PPC (N = 53) effiisions were analyzed for E-cadherin, N-cadberin and P-cadherin protein expression using immunocytochemistry. Results Both MM and OC/PPC cells showed frequent expression of all 3 cadherins. OC/PPC specimens expressed E-cadherin and N-cadherin in 52 of 53 cases and P-cadherin in 51 of 53 cases. MM effusions expressed E-cadherin, N-cadherin and P-cadherin in 22 of 24, 21 of 24 and 23 of 24 cases, respectively. The differences in the percentage of cadherin-positive cells was weakly Significant for P-cadherin (higher expression in MM, p = 0.04), but E-cadherin and N-cadherin expression was comparable (p > 0.05). Conclusion MM and OC/PPC coexpress different cadherin family members. P-cadherin, E-cadherin and N-cadherin are not useful for differentiation between OC/PPC and MM in effusions.
引用
收藏
页码:603 / 607
页数:5
相关论文
共 50 条
  • [1] Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expression
    Sivertsen, Stine
    Hadar, Rivka
    Elloul, Sivan
    Vintman, Lina
    Bedrossian, Carlos
    Reich, Reuven
    Davidson, Ben
    [J]. LUNG CANCER, 2006, 54 (03) : 309 - 317
  • [2] Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expression
    Sivertsen, S.
    Hadar, R.
    Elloul, S.
    Vintman, L.
    Bedrossian, C.
    Reich, R.
    Davidson, B.
    [J]. LUNG CANCER, 2006, 54 : S23 - S23
  • [3] T cell phenotype and receptor expression in pleural effusions associated with malignant mesothelioma
    McDonnell, A.
    Chee, J.
    Nowak, A.
    Robinson, B.
    Lake, R.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 207 - 208
  • [4] FOLATE RECEPTOR IN MALIGNANT EFFUSIONS OF OVARIAN-CARCINOMA
    HOLM, J
    HANSEN, SI
    HOIERMADSEN, M
    HELKJAER, PE
    BZOREK, M
    [J]. APMIS, 1995, 103 (09) : 663 - 670
  • [5] Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions
    Yuan, Yuan
    Nymoen, Dag Andre
    Dong, Hiep Phuc
    Bjorang, Ola
    Shih, Ie-Ming
    Low, Philip S.
    Trope, Claes G.
    Davidson, Ben
    [J]. HUMAN PATHOLOGY, 2009, 40 (10) : 1453 - 1460
  • [6] Expression of human mammaglobin gene in pleural effusions of patients with malignant mesothelioma
    Carletti, AM
    Roncella, S
    Canessa, PA
    Pratticò, L
    Maggiani, R
    Bacigalupo, B
    Ferro, P
    Fedeli, F
    [J]. THORAX, 2006, 61 (03) : 271 - 271
  • [7] OUTCOME OF PLEURODESIS FOR MALIGNANT EFFUSIONS IN MESOTHELIOMA
    Fysh, E. T. H.
    Tan, S. K.
    Read, C. A.
    Lee, F.
    Mackenzie, K.
    Weerasena, I.
    Musk, A. W.
    Lee, Y. C. G.
    [J]. RESPIROLOGY, 2012, 17 : 56 - 56
  • [8] E-cadherin and α-, β-, and γ-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions
    Davidson, B
    Berner, A
    Nesland, JM
    Risberg, B
    Berner, HS
    Tropè, CG
    Kristensen, GB
    Bryne, M
    Florenes, VA
    [J]. JOURNAL OF PATHOLOGY, 2000, 192 (04): : 460 - 469
  • [9] E-cadherin expression in ovarian carcinoma
    [J]. Nature Clinical Practice Oncology, 2005, 2 (1): : 6 - 6
  • [10] Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma
    DeLong, P
    Carroll, RG
    Henry, AC
    Tanaka, T
    Ahmad, S
    Leibowitz, MS
    Sterman, DH
    June, CH
    Albelda, SM
    Vonderheide, RH
    [J]. CANCER BIOLOGY & THERAPY, 2005, 4 (03) : 342 - 346